BRUNO, Benedetto
BRUNO, Benedetto
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA.
2010-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
2 Gy TBI vs. Flu / 2 Gy TBI Conditioning for Hematologic Malignancies in HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival
2011-01-01 Brian Kornblit; Barry Storer; Rainer F. Storb, Parameswaran Hari; Thoralf Lange; Richard T. Maziarz; Thomas Chauncey; Michael Pulsipher; Benedetto Bruno; Finn Bo Petersen; Wolfgang A. Bethge; Kai Hübel, Jan Storek, MD, David G. Maloney, Brenda M. Sandmaier
A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients
2012-01-01 Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini
A method for immunomagnetic separation of CD34+ canine hematopoietic progenitors for stem cell transplantation.
1997-01-01 Bruno B; Wallace PM; Nash RA; Andrews RG; Storb R; McSweeney PA
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
2014-01-01 Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.
2007-01-01 B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL
2007-01-01 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
A RANDOMIZED PHASE III TRIAL INVESTIGATING 2 Gy TBI VS. Flu/2 Gy TBI CONDITIONING FOR HLA-MATCHED RELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TEMPO OF CD3 AND NK CELL ENGRAFTMENT DETERMINES RELAPSE AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC
2012-01-01 Kornblit B; Storer B; Storb RF; Hari P; Vuciniv V; Maziarz RT; Chauncey T; Pulsipher MA; Bruno B; Petersen FB; Bethge WA; Hubel K; Storek J; Maloney DG; Sandmaier BM
A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables.
2010-01-01 Boglarka Gyurkocza; Rainer Storb; Barry E. Storer; Thomas Chauncey; Thoralf Lange; Ginna G. Laport; Amelia Langston; Michael A. Pulsipher; Christopher Bredeson; Richard Maziarz; Benedetto Bruno; Finn Petersen; Michael Maris; Edward Agura; Andrew M. Yeager; Wolfgang A. Bethge; Firoozeh Sahebi; Frederick R. Appelbaum; David G. Maloney; Elihu H. Estey; and Brenda M. Sandmaier
A SALVAGE TREATMENT CONTAINING NOVEL AGENTS CONSOLIDATED BY ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IMPROVES OUTCOME OF MULTIPLE MYELOMA PATIENTS FAILING AUTOLOGOUS TRANSPLANTATION
2011-01-01 F. PATRIARCA H. EINSELE; F. SPINA; B. BRUNO; M. ISOLA; C.NOZZOLI; A. NOZZA; A. SPEROTTO; F. MORABITO; G. STUHLER; M. FESTUCCIA; A. BOSI; R. FANIN; P. CORRADINI
ABO mismatch and haploidentical hematopoietic stem cell transplantation in AML - a report from the ALWP of the EBMT
In corso di stampa Bipin N Savani; Myriam Labopin; Jonathan Canaani; Xiao-jun Huang; Fabio Ciceri; William Arcese; Johanna Tischer; Yener Koc; Bruno Benedetto; Zafer Gülbas; Didier Blaise; Johan Maertens; Gerhard Ehninger; Emmanuelle Polge; Mohamad Mohty; Arnon Nagler
Adenovirus infections in patients undergoing bone marrow transplantation.
1997-01-01 Bruno B; Boeckh M; Davis C; Gooley T; Hackman RC
Adenovirus nephritis: A newly described clinical-pathological entity in bone marrow transplantation.
1996-01-01 Bruno B; Boeckh M; Zager D; Hackman RC
After relapse to autograft in myeloma should allograft or another autograft be done?
2013-01-01 benedetto bruno
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry
2011-01-01 Benedetto Bruno; Roberto Passera; Francesca Patriarca; Francesca Bonifazi; Vittorio Montefusco; Michele Falda; Luisa Giaccone; Mauro Montanari; Andrea Bacigalupo; Stefano Guidi; Nicola Mordini; Alessandro Rambaldi; Giuseppe Milone; Angelo Michele Carella; Pasqua Bavaro; Fabio Ciceri; Rosanna Scimè; Eduardo Benedetti; Alessandro Levis; Paola Marenco; Marco Casini; Alberto Bosi; Paolo Corradini; Giuseppe Bandini; Renato Fanin; Mario Boccadoro; and Simona Pollichieni
Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged 60 Years.
2008-01-01 Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; David G. Maloney; Georg Franke; Judith Shizuru; Thomas Chauncey; Edward Agura; Richard T. Maziarz; Firoozeh Sahebi; Amelia A Langston; James C. Wade; Michael Maris; Benedetto Bruno; Andrew M. Yeager; Michael Pulsipher; Finn Petersen; Wolfgang A. Bethge; Peter A. McSweeney; Dietger Niederwieser; Karl G. Blume; and Rainer F. Storb
Allogeneic Hematopoietic Cell Transplantation (HCT) in the Eighth Decade of Life: How Much Does Age Matter?
In corso di stampa Mohamed L. Sorror;, Brenda M. Sandmaier;, Barry Storer;, Thomas Chauncey;, Judith Shizuru;, Georg N. Franke;, Michael Pulsipher; Michael Maris; Benedetto Bruno;, Niels Smedegaard Andersen; Parameswaran Hari;, Amelia Langston;, Edward Agura;, Firoozeh Sahebi;, Richard Maziarz;, Finn Petersen; Wolfgang Bethge; Jonathan Gutman; Gitte Olesen; Andrew Yeager; Kai Hubel; William Hogan; Marco Mielcarek; George Georges; David G. Maloney; Rainer Storb
Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.
2005-01-01 Frederic Baron; R. Storb; B. Storer; D. Maloney; M. Maris; D. Niederwieser; J. Shizuru; T. Chauncey; B. Bruno; S. Forman; P. McSweeney; R. Maziarz; M. Pulsipher; E. Agura; M. Sorror; J. Wade; and B. Sandmaier
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up.
2009-01-01 Anna Dodero; Francesco Spina; Franco Narni; Francesca Patriarca; Sergio Cortelazzo; Fabio Benedetti; Fabio Ciceri; Donatella Baronciani; Rosanna Scime'; Enrico Pogliani; Alessandro Rambaldi; Francesca Bonifazi; Attilio Olivieri; Benedetto Bruno; Corrado Tarella; and Paolo Corradini
ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING A REDUCED INTENSITY CONDITIONING REGIMEN IN RELAPSED PERIPHERAL T-CELL LYMPHOMAS (PTCL): RESULTS AFTER A MEDIAN FOLLOW-UP OF 67 MONTHS
2011-01-01 Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scime R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. | 2010 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M | |
| 2 Gy TBI vs. Flu / 2 Gy TBI Conditioning for Hematologic Malignancies in HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival | 2011 | Brian Kornblit; Barry Storer; Rainer F. Storb, Parameswaran Hari; Thoralf Lange; Richard T. Maziarz; Thomas Chauncey; Michael Pulsipher; Benedetto Bruno; Finn Bo Petersen; Wolfgang A. Bethge; Kai Hübel, Jan Storek, MD, David G. Maloney, Brenda M. Sandmaier | |
| A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients | 2012 | Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini | |
| A method for immunomagnetic separation of CD34+ canine hematopoietic progenitors for stem cell transplantation. | 1997 | Bruno B; Wallace PM; Nash RA; Andrews RG; Storb R; McSweeney PA | |
| A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS | 2014 | Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro | |
| A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo. | 2007 | B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro | |
| A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL | 2007 | Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M | |
| A RANDOMIZED PHASE III TRIAL INVESTIGATING 2 Gy TBI VS. Flu/2 Gy TBI CONDITIONING FOR HLA-MATCHED RELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TEMPO OF CD3 AND NK CELL ENGRAFTMENT DETERMINES RELAPSE AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC | 2012 | Kornblit B; Storer B; Storb RF; Hari P; Vuciniv V; Maziarz RT; Chauncey T; Pulsipher MA; Bruno B; Petersen FB; Bethge WA; Hubel K; Storek J; Maloney DG; Sandmaier BM | |
| A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables. | 2010 | Boglarka Gyurkocza; Rainer Storb; Barry E. Storer; Thomas Chauncey; Thoralf Lange; Ginna G. Laport; Amelia Langston; Michael A. Pulsipher; Christopher Bredeson; Richard Maziarz; Benedetto Bruno; Finn Petersen; Michael Maris; Edward Agura; Andrew M. Yeager; Wolfgang A. Bethge; Firoozeh Sahebi; Frederick R. Appelbaum; David G. Maloney; Elihu H. Estey; and Brenda M. Sandmaier | |
| A SALVAGE TREATMENT CONTAINING NOVEL AGENTS CONSOLIDATED BY ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IMPROVES OUTCOME OF MULTIPLE MYELOMA PATIENTS FAILING AUTOLOGOUS TRANSPLANTATION | 2011 | F. PATRIARCA H. EINSELE; F. SPINA; B. BRUNO; M. ISOLA; C.NOZZOLI; A. NOZZA; A. SPEROTTO; F. MORABITO; G. STUHLER; M. FESTUCCIA; A. BOSI; R. FANIN; P. CORRADINI | |
| ABO mismatch and haploidentical hematopoietic stem cell transplantation in AML - a report from the ALWP of the EBMT | In corso di stampa | Bipin N Savani; Myriam Labopin; Jonathan Canaani; Xiao-jun Huang; Fabio Ciceri; William Arcese; Johanna Tischer; Yener Koc; Bruno Benedetto; Zafer Gülbas; Didier Blaise; Johan Maertens; Gerhard Ehninger; Emmanuelle Polge; Mohamad Mohty; Arnon Nagler | |
| Adenovirus infections in patients undergoing bone marrow transplantation. | 1997 | Bruno B; Boeckh M; Davis C; Gooley T; Hackman RC | |
| Adenovirus nephritis: A newly described clinical-pathological entity in bone marrow transplantation. | 1996 | Bruno B; Boeckh M; Zager D; Hackman RC | |
| After relapse to autograft in myeloma should allograft or another autograft be done? | 2013 | benedetto bruno | |
| Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry | 2011 | Benedetto Bruno; Roberto Passera; Francesca Patriarca; Francesca Bonifazi; Vittorio Montefusco; Michele Falda; Luisa Giaccone; Mauro Montanari; Andrea Bacigalupo; Stefano Guidi; Nicola Mordini; Alessandro Rambaldi; Giuseppe Milone; Angelo Michele Carella; Pasqua Bavaro; Fabio Ciceri; Rosanna Scimè; Eduardo Benedetti; Alessandro Levis; Paola Marenco; Marco Casini; Alberto Bosi; Paolo Corradini; Giuseppe Bandini; Renato Fanin; Mario Boccadoro; and Simona Pollichieni | |
| Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged 60 Years. | 2008 | Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; David G. Maloney; Georg Franke; Judith Shizuru; Thomas Chauncey; Edward Agura; Richard T. Maziarz; Firoozeh Sahebi; Amelia A Langston; James C. Wade; Michael Maris; Benedetto Bruno; Andrew M. Yeager; Michael Pulsipher; Finn Petersen; Wolfgang A. Bethge; Peter A. McSweeney; Dietger Niederwieser; Karl G. Blume; and Rainer F. Storb | |
| Allogeneic Hematopoietic Cell Transplantation (HCT) in the Eighth Decade of Life: How Much Does Age Matter? | In corso di stampa | Mohamed L. Sorror;, Brenda M. Sandmaier;, Barry Storer;, Thomas Chauncey;, Judith Shizuru;, Georg N. Franke;, Michael Pulsipher; Michael Maris; Benedetto Bruno;, Niels Smedegaard Andersen; Parameswaran Hari;, Amelia Langston;, Edward Agura;, Firoozeh Sahebi;, Richard Maziarz;, Finn Petersen; Wolfgang Bethge; Jonathan Gutman; Gitte Olesen; Andrew Yeager; Kai Hubel; William Hogan; Marco Mielcarek; George Georges; David G. Maloney; Rainer Storb | |
| Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes. | 2005 | Frederic Baron; R. Storb; B. Storer; D. Maloney; M. Maris; D. Niederwieser; J. Shizuru; T. Chauncey; B. Bruno; S. Forman; P. McSweeney; R. Maziarz; M. Pulsipher; E. Agura; M. Sorror; J. Wade; and B. Sandmaier | |
| Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up. | 2009 | Anna Dodero; Francesco Spina; Franco Narni; Francesca Patriarca; Sergio Cortelazzo; Fabio Benedetti; Fabio Ciceri; Donatella Baronciani; Rosanna Scime'; Enrico Pogliani; Alessandro Rambaldi; Francesca Bonifazi; Attilio Olivieri; Benedetto Bruno; Corrado Tarella; and Paolo Corradini | |
| ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING A REDUCED INTENSITY CONDITIONING REGIMEN IN RELAPSED PERIPHERAL T-CELL LYMPHOMAS (PTCL): RESULTS AFTER A MEDIAN FOLLOW-UP OF 67 MONTHS | 2011 | Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scime R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P |